Nasdaq (Nasdaq: NDAQ) announced that the trading in Surgical Science Sweden AB’s shares (short name: SUS) commenced today on Nasdaq First North in Stockholm. Surgical Science belongs to the health care sector and is the 59th company to be admitted to trading on Nasdaq’s Nordic markets* in 2017.

Surgical Science is the leading supplier of virtual reality simulators for medical training. Our training systems for laparoscopy and endoscopy are used by medical training centres and institutes worldwide for practice, validation and certification of students, surgeons, and medical doctors. Surgical Science was founded in 1999 and is headquartered in Gothenburg, Sweden. For more information, please visit

“We are pleased with the great interest in our listing and warmly welcome the new shareholders”, said Gisli Hennermark, CEO of Surgical Science Sweden AB. “Focus now is on growth so that all surgeons entering the operating room for the first time have had the chance to train, and be objectively evaluated, in a safe simulated VR environment. Growing sales of our own products together with licencing our proprietary simulation software to medical device companies will result in safety for patients as well as value creation for shareholders”.

“We welcome Surgical Science to our European growth market, Nasdaq First North,” said Adam Kostyál, SVP and Head of European listings at Nasdaq. “Surgical Science is yet another example of an innovative company joining our health care sector, and we congratulate the company on its successful Nasdaq First North listing.”

Surgical Science Sweden AB has appointed Erik Penser Bank AB as the Certified Adviser.

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm

Pin It on Pinterest